NeoPharm Investigators To Present New And Updated Clinical Data On Cintredekin Besudotox At The American Association Of Neurological Surgeons Annual Meeting

April 17, 2006 |

1 min read

--(BUSINESS WIRE)----NeoPharm, Inc. (NASDAQ/NM:NEOL - News): NeoPharm, Inc. (NASDAQ/NM:NEOL - News) clinical data presentations on cintredekin besudotox ("IL13-PE38QQR").

Events

MORE ON THIS TOPIC

Medical characters fighting the epidemic flat vector concept operation hand drawn illustration

Obesity

Analysts Home In on Safety as Novo, Lilly, Amgen Highlight Weight Loss Data at ADA

June 27, 2025

·

5 min read

·

Heather McKenzie

IN PARTNERSHIP WITH PATSNAP

Webinar: Beyond Theory: Real-World AI Wins in Life Science R&D, Faster & Smarter

June 25, 2025

·

1 min read

·

BioSpace Insights

Pictured: (From L) Joe Ross, Camille Bedrosian, Emil Kakkis and Heather McKenzie

Rare diseases

FDA Conditional Pathway Not Necessary, Rare Disease Experts Say, While Applauding Intent

June 24, 2025

·

3 min read

·

Heather McKenzie

From left to right: Jeff Quillen, Foley Hoag; Jim Cirenza, DNB Bank; Andrew Meadow, Health Innovation Capital; Greg Benning, Back Bay Life Science Advisors; Jonathan Gertler, Back Bay Life Science Advisors

Collaboration

Partner-Seeking Biotechs Find Plenty of Hands To Shake as BIO2025 Kicks Off

June 16, 2025

·

2 min read

·